US EditionNeOnc Sees Share Price Fall Since Going Public - Inside The Valley
Summary by labusinessjournal.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
NeOnc Sees Share Price Fall Since Going Public - Inside The Valley
The share price of NeOnc Technologies Holdings Inc. has dropped in the weeks since the company went public last month. The Westlake Village clinical-stage biopharmaceutical company, which focuses on treatments for brain cancer, had its direct listing open at $25 on March 26. That day the stock closed at $12.11 – more than a 50% decrease. It then spiked by more than 36% to close at $16.55 on March 28 and then fell to reach a low closing price of …
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
